Sanem Kayhan

Sanem Kayhan

Auto-generated profile, based on publicly available information

Sanem Kayhan

Ankara Etlik City Hospital, Ankara, Turkey, Turkey (Türkiye)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021
Verified
Journal Article
Closed access
SKS. Kayhan
S. Kayhan
BAB. Selcan Akyol
B. Selcan Akyol
MEM. Ergul
M. Ergul
CBC. Baysan
C. Baysan

8 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAli Kirik
Ali Kirik
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
Nizameddin KocaNizameddin Koca
Nizameddin Koca
TKTurkan Pasali Kilit
Turkan Pasali Kilit
SSsibel demiral sezer
sibel demiral sezer
TDTeoman Doğru
Teoman Doğru
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence data in Türkiye is limited. We aimed to determine the nationwide prevalence of MASLD and advanced hepatic fibrosis risk in subjects with cardiometabolic risk factors (CMRF). Despite recent international consensus redefining fatty liver disease terminology, no nationwide MASLD study has been reported in Türkiye. Methods: This cross-sectional study included 14,371 adults with ≥1 CMRF from 44 centers across 31 cities. MASLD was diagnosed using liver ultrasonography plus cardiometabolic criteria. Advanced fibrosis risk was assessed by fibrosis-4 (FIB-4) score (≥1.3 for ≤65 years; ≥2.0 for >65 years). Logistic regression was used to identify independent predictors of high FIB-4. Results: A total of 61.4% of participants were women, the mean age was 51.3 ± 14.4 years, and the mean BMI was 31.4 ± 6.0 kg/m2. MASLD prevalence was 75.7% (n = 10,873), rising with the number of CMRFs (56.5% with one factor vs. 83.4% with all). The prevalence of high FIB-4 scores was 12.0% overall, being lower in MASLD patients than non-MASLD patients (11.2% vs. 14.4%, p < 0.001). FIB-4 scores decreased with increasing BMI (28.1% underweight vs. 8.7% class III obesity). Male sex, T2DM, and hypertension independently predicted high FIB-4 scores, while smoking, higher BMI, and MASLD were inversely associated. Conclusions: Three-quarters of Turkish adults with CMRF have MASLD. Standard FIB-4 thresholds may underestimate fibrosis risk in obese and smoking populations, underscoring the need for adjusted cut-offs or alternative tools. This study is the first to provide nationwide MASLD prevalence data in Türkiye.

26 June 2022 in Journal of Medical Virology
Verified
Journal Article
Closed access
TUTülay Ünver Ulusoy
Tülay Ünver Ulusoy
CHCan H. Hekimoğlu
Can H. Hekimoğlu
SKSanem Kayhan
Sanem Kayhan
NAnilgün altın
nilgün altın
IŞİrFan Şencan
İrFan Şencan

1 October 2021 in International Journal for Vitamin and Nutrition Research
Verified
Journal Article
Closed access
SKSanem Kayhan
Sanem Kayhan
NKNazli Gulsoy Kirnap
Nazli Gulsoy Kirnap
MTMercan Tastemur
Mercan Tastemur
Vitamin B12 deficiency may have indirect cardiovascular effects in addition to hematological and neuropsychiatric symptoms. It was shown that the monocyte count-to-high density lipoprotein cholesterol (HDL-C) ratio (MHR) is a novel cardiovascular marker. In this study, the aim was to evaluate whether MHR was high in patients with vitamin B12 deficiency and its relationship with cardiometabolic risk factors. The study included 128 patients diagnosed with vitamin B12 deficiency and 93 healthy controls. Patients with vitamin B12 deficiency had significantly higher systolic blood pressure (SBP), diastolic blood pressure (DBP), MHR, C-reactive protein (CRP) and uric acid levels compared with the controls (median 139 vs 115 mmHg, p < 0.001; 80 vs 70 mmHg, p < 0.001; 14.2 vs 9.5, p < 0.001; 10.2 vs 4 mg/dl p < 0.001; 6.68 vs 4.8 mg/dl, p < 0.001 respectively). The prevalence of left ventricular hypertrophy was higher in vitamin B12 deficiency group (43.8%) than the control group (8.6%) (p < 0.001). In vitamin B12 deficiency group, a positive correlation was detected between MHR and SBP, CRP and uric acid (p < 0.001 r:0.34, p < 0.001 r:0.30, p < 0.001 r:0.5, respectively) and a significant negative correlation was detected between MHR and T-CHOL, LDL, HDL and B12 (p < 0.001 r: −0.39, p < 0.001 r: −0.34, p < 0.001 r: −0.57, p < 0.04 r: −0.17, respectively). MHR was high in vitamin B12 deficiency group, and correlated with the cardiometabolic risk factors in this group, which were SBP, CRP, uric acid and HDL. In conclusion, MRH, which can be easily calculated in clinical practice, can be a useful marker to assess cardiovascular risk in patients with vitamin B12 deficiency.

3 June 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
SKSanem Kayhan
Sanem Kayhan
SHSema Hepsen
Sema Hepsen
HKHatice Kozan Kalkisim
Hatice Kozan Kalkisim
ISIbrahim Nahit Sendur
Ibrahim Nahit Sendur
FAFatma Aybala Altay
Fatma Aybala Altay
AYAli Yalcindag
Ali Yalcindag
Objective: This study aims to evaluate potential pancreas endocrine damage due to SARS-CoV-2 by measuring β-cell autoantibodies in COVID-19 patients. Subjects and methods: Between June and July 2020, 95 inpatients with a positive COVID-19 test result after polymerase-chain-reaction (PCR) and who met the inclusion criteria were enrolled in our study. Laboratory parameters that belong to glucose metabolism and β-cell autoantibodies, including anti-islet, anti-glutamic acid decarboxylase, and anti-insulin autoantibodies, were measured. β-cell autoantibodies levels of the patients were measured during [...] ABSTRACT Objective: This study aims to evaluate potential pancreas endocrine damage due to SARS-CoV-2 by measuring β-cell autoantibodies in COVID-19 patients. Subjects and methods: Between June and July 2020, 95 inpatients with a positive COVID-19 test result after polymerase-chain-reaction (PCR) and who met the inclusion criteria were enrolled in our study. Laboratory parameters that belong to glucose metabolism and β-cell autoantibodies, including anti-islet, anti-glutamic acid decarboxylase, and anti-insulin autoantibodies, were measured. β-cell autoantibodies levels of the patients were measured during

29 December 2021 in Harran Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
PDF file
SKSanem Kayhan
Sanem Kayhan
HKHatıce KOZAN
Hatıce KOZAN
Amaç: COVID-19 hastalarının yönetimindeki önemli gelişmelere rağmen, tedaviyi yönlendirecek, hastalık şid-detini öngören belirteçlere ihtiyaç vardır. Biz de bu çalışmada; C-reaktif protein/Albumin (CRP/Alb) oranının hastalık şiddeti ile ilişkisini ve yoğun bakım ihtiyacını tahmin etmedeki rolünü değerlendirmeyi amaçladık.Materyal ve metod: Ocak 2021 ile Haziran 2021 tarihleri arasında hastanemizde COVID-19 enfeksiyonu nede-niyle takip edilen hastaların klinik bulguları, laboratuar sonuçları ve akciğer bilgisayarlı tomografisi retrospektif olarak incelendi. Toplam 131 hasta ve benzer yaş ve cinsiyetteki 81 sağlıklı kontrol grubu çalışmaya dahil edildi. CRP, albumin ve CRP/Alb oranı verileri analiz edildi ve COVID-19 hastaları ile sağlıklı kontrol grubu arasında kar-şılaştırıldı.Bulgular: COVID-19 hastaları ile sağlıklı kontrol grubunun yaş ortalaması ve cinsiyet dağılımı benzerdi (sırası ile p= 0.1 p= 0.31). COVID-19 hastalarının CRP/Alb oranı kontrol grubuna göre anlamlı yüksekti (p< 0.009). COVID-19 hastaları klinik durumlarına göre kritik ve non-kritik olarak sınıflandırıldığında; kritik hastalar non-kritik has-talara göre daha yaşlı (p< 0.001) ve CRP/Alb oranı daha yüksekti (p<0.001). Yapılan ROC analizinde CRP/Alb oranı cut-off 14.7 mg/dl alındığında 89% duyarlılıkla ve 91% özgüllük ile COVID-19 kritik klinik durumu predikte etti.Sonuç: Sonuç olarak, CRP/Alb oranı, rutin olarak kullanılabilecek pratik, ucuz ve kolay erişilebilir bir testdir. Ça-lışmamızda; CRP/Alb oranı yoğun bakım ihtiyacı olan kritik COVID-19 hastalarını ayırt etmede potansiyel bir pa-rametre olarak tespit edilmiştir.Anahtar Kelimeler: COVID-19, C-reaktif protein/Albumin, Prediktif